Cargando…
Obeticholic Acid Inhibits Anxiety via Alleviating Gut Microbiota-Mediated Microglia Accumulation in the Brain of High-Fat High-Sugar Diet Mice
Anxiety is one of the complications of metabolic disorders (MDs). Obeticholic acid (OCA), the bile acids (BAs) derivative, is a promising agent for improving MDs in association with gut dysbiosis. Yet, its protective effect on MDs-driven anxiety remains unknown. Here, we assessed the serum biochemic...
Autores principales: | Wu, Li, Han, Yuqiu, Zheng, Zhipeng, Zhu, Shuai, Chen, Jun, Yao, Yuanyuan, Yue, Siqing, Teufel, Andreas, Weng, Honglei, Li, Lanjuan, Wang, Baohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999854/ https://www.ncbi.nlm.nih.gov/pubmed/33803974 http://dx.doi.org/10.3390/nu13030940 |
Ejemplares similares
-
Cefminox sodium alleviates the high-fat high-sugar-fed mice's hepatic fatty accumulation via multiple pathways
por: Xiao, Leming, et al.
Publicado: (2023) -
Alterations in Faecal and Serum Metabolic Profiles in Patients with Neovascular Age-Related Macular Degeneration
por: Yuan, Qixian, et al.
Publicado: (2023) -
Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis
por: Zhou, Jiyu, et al.
Publicado: (2019) -
Obeticholic acid ameliorates severity of Clostridioides difficile infection in high fat diet-induced obese mice
por: Jose, Shinsmon, et al.
Publicado: (2020) -
Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat
por: Zhang, Hanlin, et al.
Publicado: (2021)